Explore safer IBS treatment choices for primary care: lifestyle steps and newer diarrhea/constipation meds beyond antidepressants and opioids.
Ali Rezaie, MD
Advertisement
Ali Rezaie, MD, is medical director of the GI Motility Program at Cedars-Sinai.
Articles by Ali Rezaie, MD
Experts weigh antidepressants for IBS: small but serious mortality risk, while FDA-approved IBS drugs show stronger trials and long-term safety.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Patient Care Online
1
New Childhood Vaccine Executive Order Draws Criticism From AAP, AMA, NFID
2
Reminders for Primary Care Physicians, Patients Improved Annual Lung Cancer Screening Adherence
3
Freenome Lung Cancer Blood Test Receives FDA Breakthrough Device Status
4
How Primary Care Physicians Can Target Midlife Vascular Risk to Support Brain Health
5